Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.


BACKGROUND In vivo proton magnetic resonance spectroscopy is a safe and noninvasive tool that can be used to study aspects of brain chemistry and metabolism. This study was designed to evaluate its role in routine application to reveal the diagnostic reasons for cognitive impairment. METHOD 37 Alzheimer's disease patients (NINCDS-ADRDA criteria), 31… (More)


  • Presentations referencing similar topics